%0 Editorial
%T The interferon story continues: EORTC CLTG study explores pegylated interferon α-2a's role in treating mycosis fungoides/Sézary syndrome.
%A Stadler R
%J Br J Dermatol
%V 191
%N 3
%D 2024 Aug 14
%M 38703059
%F 11.113
%R 10.1093/bjd/ljae188